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Hair Growth Defects in Insig-Deficient Mice Caused
by Cholesterol Precursor Accumulation and Reversed
by Simvastatin
Bret M. Evers1, Midhat S. Farooqi1, John M. Shelton2, James A. Richardson3, Joseph L. Goldstein1,
Michael S. Brown1 and Guosheng Liang1
Insig-1 and Insig-2, two closely related proteins, are essential for feedback inhibition of cholesterol
biosynthesis. Here, we characterized a line of epidermal-specific, Insig-double knockout (Epi-Insig-DKO) mice
lacking both Insigs in epidermis. At birth, Epi-Insig-DKO mice were indistinguishable from control littermates,
but thereafter they failed to thrive and died before 6 weeks of age. By 14 days of age, 100% of Epi-Insig-DKO
mice exhibited defects in hair growth along with other skin abnormalities, including hyperkeratosis. Hair
follicles in Epi-Insig-DKO mice developed normally through postnatal day 7, but they failed to progress to later
stages and thus exhibited defects in postnatal hair cycling. Insig deficiency caused a marked buildup
of cholesterol precursors in skin associated with a marked increase in 3-hydroxy-3-methylglutaryl coenzyme
A reductase protein. Topical treatment of Epi-Insig-DKO mice with simvastatin, an inhibitor of reductase,
reduced sterol precursors in skin and corrected the hair and skin defects. We conclude that Insig deficiency in
skin causes accumulation of cholesterol precursors, and this impairs normal hair development. These findings
have implications for several human genetic diseases in which mutations in cholesterol biosynthetic enzymes
lead to accumulation of sterol precursors and multiple cutaneous abnormalities.
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INTRODUCTION
Cholesterol has an essential role in mammalian development,
and its concentration is tightly regulated by a feedback
system that senses the level of cholesterol in cell membranes
and modulates the rates of cholesterol synthesis (Brown and
Goldstein, 2009). At the core of this feedback regulation are
Insig-1 and Insig-2, two closely related endoplasmic reticu-
lum membrane proteins. Under conditions of sterol excess,
Insigs limit cholesterol synthesis by enhancing the ubiquiti-
nation and degradation of 3-hydroxy-3-methylglutaryl coen-
zyme A reductase (HMG-CoA reductase), the rate-limiting
enzyme of cholesterol biosynthesis. In addition, excess sterols
cause Insigs to inhibit the action of Scap, a polytopic
membrane protein that transports sterol regulatory element-
binding proteins (SREBPs) from the endoplasmic reticulum to
the Golgi apparatus (Goldstein et al., 2006).
Sterol regulatory element-binding proteins are membrane-
bound transcription factors required for transcription of
all of the known genes encoding enzymes of the cholesterol
biosynthetic pathway (Horton et al., 2002). To enter
the nucleus, inactive SREBP precursors must be transported
by Scap to the Golgi, where they are processed
proteolytically to yield active nuclear fragments (nSREBPs).
When sterols accumulate to high levels within cells, Insigs
bind and retain the Scap/SREBP complex in the endoplasmic
reticulum, preventing the generation of active nSREBPs
and thereby reducing transcription of cholesterol bio-
synthetic genes. By controlling both the stability of HMG-
CoA reductase protein and the generation of active nSREBPs,
the net result of Insig action is to decrease cholesterol
synthesis whenever sterol levels are high (Brown and
Goldstein, 2009).
The essential role of Insig-mediated regulation of choles-
terol homeostasis in vivo was shown by our previous studies
of mice lacking both Insig-1 and Insig-2 (Engelking et al.,
2005, 2006). In these Insig double knockout (Insig-DKO)
mice, Insig deficiency caused an overproduction of choles-
terol and a marked buildup of cholesterol precursors, which
led to craniofacial abnormalities. The teratogenic role of
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sterol intermediates in causing the craniofacial defects was
supported by the observation that facial clefting in Insig-DKO
mice decreased when pregnant females were treated with
lovastatin, an inhibitor of HMG-CoA reductase that lowers
the level of cholesterol and its sterol precursors (Engelking
et al., 2006). We postulated that the teratogenic effects were
caused by the accumulation of sterol precursors, but the
mechanism remained unknown. The neonatal lethality of the
Insig-DKO mice precluded us from examining whether
excess sterol precursors impair developmental processes that
occur after birth.
Inasmuch as palatal development requires the interaction
between epithelial and mesenchymal cells (Gritli-Linde,
2007), we set out to examine whether the clefting
defects in Insig-DKO mice are caused by excess sterol
precursors in epithelial and/or mesenchymal cells of the
palate. Accordingly, in this study we generated a tissue-
specific line of knockout mice lacking both Insig-1 and Insig-
2 in the oral epithelium. These mice also lacked Insigs in the
epidermis of the skin (termed Epi-Insig-DKO mice). Epi-Insig-
DKO mice did not manifest any craniofacial abnormalities,
indicating that loss of Insigs in the oral epithelium is not
sufficient to produce cleft palate. Instead, Epi-Insig-DKO
mice exhibited defects in hair growth and other skin
abnormalities, associated with a marked accumulation of
sterol precursors in the skin. The causal role of sterol
precursors is supported by the observation that the hair
and skin defects were completely corrected by topical
application of a statin inhibitor of HMG-CoA reductase that
lowered the elevated sterol precursors in the skin. These
findings have implications for the pathogenesis of skin
abnormalities seen in several inborn errors of cholesterol
synthesis, such as the CHILD syndrome (congenital hemi-
dysplasia with ichthyosiform nevus and limb defects) and the
CDPX2 syndrome (X-linked dominant chondrodysplasia
punctata type 2), both of which exhibit a buildup of sterol
precursors in skin.
RESULTS
Generation of mice lacking Insig-1 and Insig-2 in the epidermis
Mice carrying floxed Insig-1 and null Insig-2 alleles
(Insig-1f/f;Insig-2/) (Engelking et al., 2005) were bred to
Keratin14-Cre (K14-Cre) transgenic mice in which Cre recom-
binase is driven by the human Keratin14 promoter that is
expressed in the oral epithelium, epidermis, and hair follicles
(Dassule et al., 2000; Gritli-Linde et al., 2007). The K14-Cre-
mediated deletion of Insig-1 (Figure 1a), in combination with
the germ-line deletion of Insig-2, rendered the resulting
Insig-1f/f;Insig-2/;K14-Cre mice deficient in both Insig-1 and
Insig-2 in these tissues. For simplicity, we designated these Insig-
1f/f;Insig-2/;K14-Cre mice as epidermal-specific Insig-DKO
(Epi-Insig-DKO) mice. For all experiments described here, we
bred Insig-1f/wt;Insig-2/;K14-Cre male and Insig-1f/f;Insig-2/
female mice to obtain control Insig-1f/f;Insig-2/ and Epi-Insig-
DKO littermates. At 18.5 days post coitum (dpc), Epi-Insig-DKO
mice were observed in the expected 1:1:1:1 Mendelian ratio
(based on 42 litters). At birth, mutant mice were grossly
indistinguishable from wild-type littermates.
In Figure 1b, we used real-time PCR to quantify the
relative amount of Insig-1 mRNA in the skin and liver from
postnatal day 14 (PND 14) control and Epi-Insig-DKO mice.
Compared with control mice, the amount of Insig-1 mRNA in
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Figure 1. Generation of mice lacking Insigs in the epidermis. (a) Schematic
of epidermal-specific deletion of Insig-1. Mice carrying floxed Insig-1 and null
Insig-2 alleles (Insig-1f/f;Insig-2/) were bred to Keratin14-Cre (K14-Cre)
transgenic mice in which Cre recombinase driven by the human Keratin14
promoter was expressed in the oral epithelium, epidermis, and hair follicles.
This Cre-mediated deletion of Insig-1, in combination with the germ-line
deletion of Insig-2, generated mice that lacked both Insig-1 and Insig-2 in
these tissues. Because the epidermis was the major tissue in which Insigs were
ablated, we designated these mutant mice as epidermal-specific Insig-double
knockout (Epi-Insig-DKO) mice. (b) Total RNA was isolated from back skins
and livers of postnatal day 14 (PND 14) littermate control (Insig-1f/f;Insig-2/)
and Epi-Insig-DKO mice. Relative amount of Insig-1 mRNA was determined
by quantitative real-time PCR using the comparative Ct method. Each bar
represents the mean±SEM of data from five mice. The Ct (cycle threshold)
numbers are shown inside the bars. (c) Body weights of littermate control and
Epi-Insig-DKO mice were measured at various ages. Each bar represents the
mean±SEM of data from the indicated number of mice. Statistical analysis
was performed with the two-tailed Student’s t-test.
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the skin of Epi-Insig-DKO mice was reduced by 93%. Liver
Insig-1 mRNA levels were comparable between control and
Epi-Insig-DKO mice. Therefore, the K14-Cre-mediated re-
combination led to an efficient and skin-specific ablation of
Insig-1 in Epi-Insig-DKO mice, consistent with previous
studies in which the same K14-Cre was used to delete other
floxed genes in the skin (Wang et al., 2006; Gritli-Linde et al.,
2007).
Although Epi-Insig-DKO mice were grossly indistinguish-
able from control littermates at birth, they failed to thrive, and
none survived beyond 6 weeks after birth. The cause of death
remains to be determined, but did not appear to result from
any detectable gross abnormality in the oral epithelium.
Figure 1c shows the body weights of control and Epi-Insig-
DKO mice at various ages before death. At 18.5 dpc, Epi-
Insig-DKO embryos weighed the same (1.21 g; mean of 99
embryos) as control littermates (1.22 g; mean of 101
embryos). In experiments not shown, both control and
mutant 18.5-dpc embryos exhibited an intact epidermal
barrier as measured by the X-gal staining assay (Hardman
et al., 1998). At PND 4, the mutant mice (1.77 g) were 27%
smaller than controls (2.44 g) (Figure 1c). As the mice aged,
this difference became more dramatic such that by PND 28
mutant mice (5.93 g) were 63% smaller than controls
(15.83 g) (Figure 1c).
Most strikingly, Epi-Insig-DKO mice failed to grow body
hair. At PND 14, all of the control mice (44 out of 44) had a
full coat of body hair, whereas none of the Epi-Insig-DKO
mice (0 out of 48) had any body hair (Figure 2a). Other gross
abnormalities in the mutant mice included hyperkeratosis,
kinking of the vibrissae (whiskers), and exophthalmos
(compare Figure 2c and b). Histological examination
revealed abnormalities in the eyes and the meibomian
glands. In the former, three out of five Epi-Insig-DKO mice
had keratitis; in the latter, five out of five showed gland
enlargement. No gross abnormalities were found in the teeth,
nails, and internal organs on necropsy.
Histological analyses of skin from control and Epi-Insig-DKO
mice
Figure 3 shows histological sections of skin from control and
Epi-Insig-DKO mice at PND 14. Whereas the hair follicles of
control mice were aligned normally (Figure 3a and inset),
those of Epi-Insig-DKO mice were misaligned, unevenly
distributed, ectatic, plugged with keratin, and contained
distorted hair shafts (Figure 3b and inset). Epi-Insig-DKO mice
also showed a loss of hypodermal adipocytes (Figure 3b) and
exhibited epidermal hyperplasia and orthokeratotic hyper-
keratosis with hypergranulosis (Figure 3d). The hyperplastic
epidermis of Epi-Insig-DKOmice was 5- to 7-cell layers thick,
whereas the epidermis of control mice was only 2- to 3-cell
layers thick. In controls, the dermal papillae were enveloped
by follicular epithelial cells to form normal hair bulbs (Figure
3e). In contrast, the dermal papillae of Epi-Insig-DKO mice
were condensed and separated from the follicular epithelial
cells, associated with degeneration of the hair bulbs (Figure
3f). A slight infiltration of neutrophils was noted in the dermis,
but not in the hair follicles.
Growth of hair follicles is divided into two distinct stages:
(1) follicular morphogenesis in which the hair follicle
develops and grows from embryonic precursors, and (2) the
follicular cycle (or hair cycle) whereby hair follicles grow
(anagen), regress (catagen), and rest (telogen), producing new
hairs throughout the mammalian lifetime (Alonso and Fuchs,
2006; Schneider et al., 2009). In mice, follicular morphogen-
esis begins on the upper back at 14.5 dpc. The ectoderm
elongates and invaginates, and mesenchymal cells beneath
the invaginated ectoderm condense to form the hair placode.
The invaginated ectoderm will differentiate into the hair
follicle and adjacent epidermis, whereas the mesenchymal
cell condensation will become the dermal papilla. After birth,
between PNDs 6 and 8, the hair follicles of the back become
fully mature, and the cells within the hair bulb continue to
proliferate and differentiate, causing the hair shaft to erupt
from the skin surface. Around PND 16, when follicular
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Figure 2. Gross morphology of control and Epi-Insig-DKO mice. (a–c)
Representative photographs of control and Epi-Insig-DKO littermates at
postnatal day (PND) 14. Compared with control mice (a, left), all mutant mice
(a, right) were smaller in size, exhibited thickening and flaking of the skin, and
failed to grow body hair. Epi-Insig-DKO mice (c) also exhibited exophthalmos
and short, kinked vibrissae compared with control mice (b). Scale
bars¼ 1.0 cm (a–c).
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morphogenesis is complete, hair follicles enter the catagen
phase of the first follicular cycle and begin to regress. By PND
19, the hair follicles progress to telogen that lasts for 1–2 days.
At the end of telogen, the hair follicles enter the first anagen
phase of the follicular cycle and remain in this phase until
catagen begins again roughly 6 weeks after birth, after which
the follicular cycle repeats anew.
To further characterize the hair follicle defects of Epi-Insig-
DKO mice, we compared hair follicle development between
control and Epi-Insig-DKO mice at PNDs 4, 7, 14, 21, and 28
(Figure 4). At PND 4, hair follicles were histologically similar
in control (Figure 4a) and Epi-Insig-DKO (Figure 4f) mice. At
PND 7, some hair shafts in Epi-Insig-DKO mice had become
kinked (Figure 4g and inset). Near the completion of follicular
morphogenesis at PND 14, the hair follicles of control mice
were aligned (Figure 4c), whereas the hair follicles of Epi-
Insig-DKO had become misaligned and unevenly dispersed
(Figure 4h). The hair follicles from these mutant mice also
exhibited ectasia, kinked hair shafts, dermal papillae con-
densation, and hair bulb degeneration. Epi-Insig-DKO mice
also showed a loss of hypodermal adipocytes compared with
control mice. At PND 21, when hair follicles of control mice
were in the telogen phase of the follicular cycle (Figure 4d),
those of Epi-Insig-DKO mice were arrested and exhibited
progressive ectasia, with keratin accumulation within the
follicles (Figure 4i). This arrest of hair follicle cycling
persisted in the Epi-Insig-DKO mice at PND 28 with further
enlargement of the hair follicles along with minimally
detectable scarring (Figure 4j). Because the hair follicles
were extremely ectatic at this stage, it was difficult to
determine whether follicular drop out had occurred. In
control mice at PND 28, hair follicles proceeded into the
anagen phase normally (Figure 4e).
Elevation in cholesterol precursors in skin of Epi-Insig-DKO
mice and reduction by simvastatin treatment
In our previous studies of germ-line Insig-DKO mice, we
showed that Insig deficiency caused an overproduction and
marked buildup of sterol precursors of cholesterol that led to
craniofacial abnormalities (Engelking et al., 2006). We
therefore explored the possibility that the skin abnormalities
in Epi-Insig-DKO mice were also due to the accumulation of
sterol precursors. As a first step to test this hypothesis, we
used oil red O to stain the neutral lipids in skin sections from
control and Epi-Insig-DKO mice (Figure 5). At PND 14,
sebaceous glands were enlarged and filled with lipids in Epi-
Insig-DKO (Figure 5c) compared with those of control (Figure
5a) mice. Quantification of sebaceous gland area revealed
that the sebaceous glands of Epi-Insig-DKO mice were 1.7-
fold larger in cross-section than those of control mice
(2,045±101 vs. 1,236±35 mm2, Po0.001). Lipids also
accumulated in the epidermal compartment of the hair bulbs
in Epi-Insig-DKO mice (Figure 5d), but not in those of control
mice (Figure 5b).
We next carried out immunoblot analysis to determine the
protein levels of HMG-CoA reductase in the skin of PND 14
control and Epi-Insig-DKO mice. As shown in Figure 5e, the
relative amount of HMG-CoA reductase protein in the skin of
Epi-Insig DKO mice was 10-fold higher than that in control
mice (mean of four values in each group). These relative
values were determined by densitometric quantification of
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Figure 3. Histology of skin from control and Epi-Insig-DKO mice. Skin from
the upper back of postnatal day (PND) 14 littermate control and Epi-Insig-DKO
mice was fixed, sectioned parallel (a, b, e, f) or perpendicular (c, d) to the hair
shaft, and stained with hematoxylin and eosin. Shown here are sections
representative of five mice in each group. (a, b) Epi-Insig-DKO mice showed a
loss of hypodermal adipocytes, misalignment, and ectasia of hair follicles
(white arrowhead), and kinking of hair shafts (compare inset of b with the inset
of a). (c, d) Epi-Insig-DKO mice exhibited epidermal hyperplasia (black double
arrows). The dashed line represents the border between the epidermis and
dermis. (e, f) The dermal papillae (white arrows) of Epi-Insig-DKO mice
separated from the follicular epithelial cells of the hair bulb (hb), leading to its
degeneration. Scale bars¼0.1mm (a, b) and 0.05mm (c–f, insets of a and b).
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the reductase protein band relative to that of the transferrin
protein band (loading control). Figure 5g shows the
marked overabundance of reductase protein in the sebaceous
glands of the mutant mice, as revealed by immunohisto-
chemistry.
Figure 6a shows an abridged diagram of the cholesterol
biosynthetic pathway, depicting the major sterol precursors.
Also shown is the enzyme HMG-CoA reductase, which
converts HMG-CoA to mevalonate and is the target for the
statin class of drugs that inhibit cholesterol synthesis
(Goldstein and Brown, 1990). We determined the levels
of cholesterol and its precursors in skin from control and
Epi-Insig-DKO mice using gas chromatography-mass spectro-
scopy (GC-MS). In the experiments shown in Figure 6b–g, we
treated entire litters of mice daily from PND 2 to PND 13 with
topical applications of vehicle or the cholesterol synthesis
inhibitor simvastatin. We used a protocol in which acetone is
rubbed on the skin to disrupt the permeability barrier before
application of the vehicle or simvastatin (Feingold et al.,
1990). The drug was applied to a patch of skin 0.5–1 cm2
located between the shoulder blades. At PND 14, after the
mice were photographed, skin from the upper back was
harvested for sterol measurements, and tail tissues were used
for genotyping. The skin of vehicle-treated Epi-Insig-DKO
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Figure 4. Hair follicle morphogenesis and cycling in control and Epi-Insig-DKO mice. Skin from the upper back of postnatal days (PNDs) 4, 7, 14, 21, and 28
littermate mice was fixed, sectioned parallel to the hair shaft, and stained with hematoxylin and eosin. Shown here are sections representative of five mice in
each group. (a, f) At PND 4, hair follicles were histologically identical between control (a) and Epi-Insig-DKO (f) mice. (b, g) At PND 7, some hair shafts in Epi-
Insig-DKO mice (g) had become kinked (inset of g). (c, h) By PND 14, the hair follicles of Epi-Insig-DKO mice (h) had become completely misaligned.
Furthermore, Epi-Insig-DKO mice also exhibited a loss of hypodermal adipocytes, hyperkeratosis, ectatic hair follicles (white arrowhead), kinking of the hair
shafts (compare inset of h with the inset of c), and hair bulb degeneration. (d, e, i, j) At PND 21, when hair follicles of control mice (d) were in the telogen phase
of the follicular cycle, those of Epi-Insig-DKO mice (i) were arrested and exhibited progressive ectasia of hair follicles (white arrowheads) with the accumulation
of keratin within the follicle. This arrest of hair follicle cycling persisted in the mutant mice (j) at PND 28 with further exacerbation of hair follicle abnormalities;
whereas, hair follicles of control mice (e) proceeded into the anagen phase normally. Scale bars¼ 0.1mm (a–j) and 0.05mm (insets of b, c, g, h).
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mice had elevated levels of cholesterol and its precursors
compared with that of vehicle-treated control mice. As
indicated by the black bars in Figure 6, the fold increases
ranged from 1.7-fold for desmosterol (Figure 6f) to 7.1-fold for
lathosterol (Figure 6e). When treated with simvastatin, the
cholesterol content in the skin of control mice was not
reduced, whereas the cholesterol content in the skin of Epi-
Insig-DKO mice was reduced to a level close to that of
control mice (gray bars in Figure 6g). In the skin of control
mice, simvastatin treatment significantly reduced the levels of
all of the sterol precursors (gray bars in Figure 6b-f). An even
greater relative reduction was observed in the skin of the Epi-
Insig-DKO mice with the exception of desmosterol, which
was not affected by simvastatin treatment (Figure 6f).
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Figure 5. Staining of lipids and immunological visualization of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase in skin from control and
Epi-Insig-DKO mice. (a–d) Skin from the upper back of postnatal day (PND) 14 control and Epi-Insig-DKO mice was fixed, cryosectioned, and stained
with oil red O. Shown here are representative sections from four mice per group. (a, c) Sebaceous glands (arrows) were enlarged in mutant (c) compared
with control (a) mice. (b, d) Lipids accumulated in the epidermal compartment (arrow) of the hair bulbs in mutant (d) but not in control (b) mice. (e) Immunoblot
analysis of HMG-CoA reductase in skin from the upper back of PND 14 control and Epi-Insig-DKO mice. Aliquots of whole-cell lysates (30 mg) were subjected to
8% SDS–PAGE and immunoblot analysis with a rabbit polyclonal antibody against mouse HMG-CoA reductase. Transferrin receptor was used as loading
control. Shown are results from four control (lanes 1–4) and four Epi-Insig-DKO (lanes 5–8) mice. (f, g) Immunohistochemical analysis of HMG-CoA reductase
in skin from upper back of PND 14 control (f) and Epi-Insig-DKO (g) mice. Shown are sections representative of five mice in each group. Sebaceous
glands (arrows) of Epi-Insig-DKO mice (g) showed a massive increase in reductase protein compared with those of control mice (f). Scale bars¼0.1mm
(a, c), 0.01mm (b, d), and 0.02mm (f, g).
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Simvastatin-mediated correction of hair defects in
Epi-Insig-DKO mice
Figure 7 shows the overall appearances and histological
analyses of control and Epi-Insig-DKO mice treated with
either vehicle or 1mg simvastatin. As described earlier, entire
litters of mice were treated daily from PND 2 to PND 13 with
topical applications of either vehicle or simvastatin. At PND
14, the mice were photographed and scored for hair growth
by two independent observers before genotyping. The hair
growth and body weights of control mice were not affected
by simvastatin treatment (20 out of 20, Figure 7b). All (11 out
of 11) of the vehicle-treated Epi-Insig-DKO mice were
hairless, the same phenotype exhibited by untreated Epi-
Insig-DKO mice (Figure 2). Simvastatin treatment completely
corrected the hairless phenotype such that 100% (16 out of
16) of the treated mutant mice had normal hair growth (Figure
7d), no meibomian gland enlargement, and no keratitis.
Normalization of hair was observed throughout the body, and
not just in the region where the drug was applied. Simvastatin
treatment also corrected the low body weight phenotype of
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Figure 6. Sterol content in the skin of control and Epi-Insig-DKO mice treated with or without simvastatin. (a) Pathway for cholesterol biosynthesis,
showing site of inhibition by simvastatin. (b–g) Littermate control and mutant mice were treated daily with either 1mg simvastatin or vehicle from postnatal
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Student’s t-test.
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Epi-Insig-DKO mice, consistent with a widespread systemic
effect. Whereas vehicle-treated Epi-Insig-DKO mice weighed
39% less than vehicle-treated control littermates (4.84 vs.
7.97 g), simvastatin-treated Epi-Insig-DKO and control mice
had similar body weights (6.11 vs. 6.90 g). A lower dose of
simvastatin (30 mg per day from PND 2 to PND 13) only
partially corrected the phenotype; the coat was frizzled and
tattered (100% of mutant mice) and the number of hair
follicles was markedly reduced and showed abnormalities of
the type seen in Figure 3b, d, and f.
To further evaluate the effect of simvastatin treatment on
hair growth, we carried out histological analyses of skin from
all four groups of mice described above (Figure 7e–p). Neither
vehicle nor simvastatin treatment had any effect on the hair
and skin histology of control mice (Figure 7e, f, i, and j).
Vehicle-treated Epi-Insig-DKO mice (Figure 7g and k)
showed the same gross and histological defects in hair and
skin observed in untreated Epi-Insig-DKO mice (Figure 3). All
these defects were corrected in simvastatin-treated Epi-Insig-
DKO mice (Figure 7h and l). Furthermore, the accumulation
of oil red O-stained lipids seen in the epidermal compartment
of the hair bulbs of Epi-Insig-DKO mice (Figure 7o) was
prevented by simvastatin treatment (Figure 7p). Sebaceous
gland hyperplasia seen in Epi-Insig-DKO mice was also
ameliorated by simvastatin treatment (data not shown).
Analyses of control and Epi-Insig-DKO mice at different times
after stopping simvastatin treatment
In the experiments shown in Figure 7, the mice were treated
daily with simvastatin from PND 2 to PND 13 and analyzed
at PND 14. To determine whether the mice would regress
after cessation of statin treatment, we carried out another
study in which control and Epi-Insig-DKO mice were first
treated with vehicle or 1mg simvastatin from PND 2 to PND
13 and then left untreated for the next 5.5 months. The mice
were monitored weekly by two independent observers. None
(0 out of 4) of the vehicle-treated Epi-Insig-DKO mice
survived beyond 6 weeks of age. In contrast, simvastatin-
treated Epi-Insig-DKO mice lived to the 6-month end point.
Strikingly, though they were only treated with simvastatin
from PND 2 to PND 13, the Epi-Insig-DKO mice maintained
a full coat of body hair, normal body weight, and normal
claws for B3.5 months (Figure 8a). After 3.5 months, the
mutant mice began to lose hair, and body weight decreased.
By 6 months of age, the mutant mice showed a near-total loss
of body hair (Figure 8b), and their body weight was severely
reduced (23.4±0.82 vs. 32.1±1 g in controls, Po0.001).
The claws of these mice were deformed and the vibrissae
were shortened and kinked. Histological analysis of the skin
from Epi-Insig-DKO mice at 6 months of age revealed
abnormalities similar to those in Figure 3. Figure 8c-h shows
Control Epi-Insig-DKO
– Simvastatin
a
e
b
f
+ Simvastatin – Simvastatin + Simvastatin
c
g
d
h
i j k l
m n o p
Figure 7. Gross morphology and histology of control and Epi-Insig-DKO
mice treated with or without simvastatin. Littermate control and Epi-Insig-
DKO mice were treated daily with either 1mg simvastatin or vehicle from
postnatal day (PND) 2 to PND 13. (a–d) At PND 14, animals were
photographed and analyzed for hair growth by two independent observers
before genotyping. Although none (0 out of 11) of the vehicle-treated Epi-
Insig-DKO mice had body hair (c), 100% (16 out of 16) of the simvastatin-
treated Epi-Insig-DKO mice exhibited normal hair (d). Hair growth in control
mice was not affected by either vehicle (a) or simvastatin (b) treatment. (e–p)
Mice were killed at PND 14, and skin from the upper back was fixed and
either sectioned for hematoxylin and eosin staining (e-l) or cryosectioned for
oil red O staining (m–p). Shown here are sections representative of three mice
(m–p) or five mice (e–l) per group. Simvastatin treatment of mutant mice
prevented the hair follicle disorganization and degeneration (h vs. g), the hair
bulb degeneration and dermal papillae separation (l vs. k), and the
accumulation of lipid droplets (black arrows) in the epidermal compartment
of hair bulbs (p vs. o). Simvastatin treatment did not have any effect on these
histological parameters in control mice (f, j, n vs. e, i, m). Scale bars¼ 1.0 cm
(a–d) and 0.1mm (e–p).
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the sterol content of the skin from 6-month old control and
Epi-Insig-DKO mice that were treated with simvastatin only
from PND 2 to PND 13 and left untreated thereafter. The
levels of 24-dihydrolanosterol, zymosterol, lathosterol, and
cholesterol were all significantly elevated in the Epi-Insig-
DKO mice (Figure 8d–f and h). Lanosterol and desmosterol
levels did not differ significantly between control and
Epi-Insig-DKO mice (Figure 8c and g).
DISCUSSION
The present studies show that epidermal-specific ablation of
the genes encoding Insig-1 and Insig-2, two proteins required
for the feedback inhibition of cholesterol synthesis, leads to
accumulation of sterol precursors in the skin. The excess
sterol precursors impair normal hair development, producing
a hairless phenotype along with other skin abnormalities. The
causal role of sterol precursors is supported by the observa-
tion that the hair and skin defects in the mutant mice were
completely corrected by topical application of a statin
inhibitor of cholesterol synthesis that lowered the levels of
sterol precursors in the skin.
Cholesterol has an essential role in the formation and
maintenance of the epidermal permeability barrier (Feingold
et al., 1990; Feingold, 2009). To date, three human
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Figure 8. Morphology and skin sterol content of control and Epi-Insig-DKO mice at 3 and 5.5 months after stopping simvastatin. (a, b) Five
Epi-Insig-DKO mice were treated daily with 1mg simvastatin from postnatal day (PND) 2 to PND 13. Thereafter, the mice were left untreated for
5.5 months. These photographs show the same Epi-Insig DKO mouse at 3.5 months (a) and 6 months (b) of age. The loss of hair and decrease in body weight
that occurred in this mouse between 3.5 and 6 months of age was reproduced in all five mutant mice studied in this experiment. (c–h) The sterol content
in the back skin from control and Epi-Insig-DKO mice at 6 months was measured by gas chromatography–mass spectroscopy. Each bar represents the
mean±SEM of data from five mice. Statistical analysis was performed with the two-tailed Student’s t-test.
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malformation syndromes caused by inherited enzyme defects
in the cholesterol biosynthetic pathway exhibit skin defects
(Porter, 2003). These syndromes are CHILD, CDPX2, and
desmosterolosis. Inasmuch as the enzymes defective in these
syndromes catalyze different steps in the conversion of
lanosterol to cholesterol (see Figure 6a), each of these defects
leads to a deficiency in cholesterol with a concomitant
buildup of various sterol precursors proximal to the defective
enzyme. CHILD and CDPX2 patients as well as the
corresponding Bpa/Str and Td mice exhibit similar skin
defects, including ichthyosis, patchy hyperkeratosis, and
alopecia (Liu et al., 1999). Among the two reported cases
of human desmosterolosis, one exhibited cutis aplasia
(Andersson et al., 2002). The corresponding Dhcr24/ mice
showed wrinkleless taut skin and an impaired epidermal
permeability barrier; as a result, the mice died within a few
hours after birth (Mirza et al., 2006). The skin defects in these
three syndromes are caused, either singly or in combination,
by cholesterol deficiency or the accumulation of sterol
precursors.
Epi-Insig-DKO mice differ from the aforementioned
syndromes in that the accumulation of sterol precursors is
not accompanied by cholesterol deficiency. Instead, at
PND 14, the skin cholesterol content is elevated 2.2-fold in
the Epi-Insig-DKO mice (Figure 6g). Furthermore, the
Epi-Insig-DKO mice maintain an intact epidermal barrier at
18.5 dpc and do not die until about 6 weeks after birth,
suggesting that skin barrier abnormalities associated with
cholesterol deficiency do not underlie the skin and hair
defects in Epi-Insig-DKO mice. Together, these results suggest
that the defects in the Epi-Insig-DKO mice are caused by a
buildup of sterol precursors and not by a deficiency of
cholesterol. It is unclear, however, whether these defects are
caused by one specific sterol precursor or a combination of
sterol precursors.
Hair follicle growth is characterized by two distinct stages:
(1) follicular morphogenesis in which the hair follicle
develops and grows from embryonic precursors, and (2) the
follicular cycle (or hair cycle) whereby hair follicles grow
(anagen), regress (catagen), and rest (telogen) to produce new
hairs throughout the mammalian lifetime (Alonso and Fuchs,
2006; Schneider et al., 2009). Defects in any one of these
steps can lead to anomalies in hair development and growth.
The buildup of sterol precursors in the skin of Epi-Insig-DKO
mice does not affect the initial stages of follicular morpho-
genesis (up to PND 7); rather, it appears to interfere with later
stages of follicular morphogenesis and the hair cycle
(Figure 4).
The mouse mutant, hairless, which is deficient in a
transcriptional co-repressor for several genes that regulate
keratinocyte differentiation (Benavides et al., 2009), has a
hair growth phenotype similar to that of Epi-Insig-DKO mice.
However, there are two main phenotypic differences
between these two mutants: (1) the defects in hairless appear
during the first catagen (after PND 16), whereas those in
Epi-Insig-DKO appear during follicular morphogenesis
(at PND 7); and (2) hairless mice exhibit dermal cysts,
whereas Epi-Insig-DKO mice do not.
The molecular mechanism by which a buildup of sterol
precursors interferes with hair follicle growth in the Epi-Insig-
DKO mice is unknown. One possible target is the Sonic
Hedgehog (Shh) signaling pathway, which has been shown to
be important in both follicular morphogenesis and follicular
cycling (St-Jacques et al., 1998; Chiang et al., 1999). As
shown in Figure 4, Epi-Insig-DKO mice undergo normal
follicular morphogenesis up to PND 7, but fail to progress to
later stages. These abnormalities are similar but not identical
to those in Shh-deficient (Shh/) mice that undergo normal
follicular morphogenesis up to 15.5 dpc (St-Jacques et al.,
1998; Chiang et al., 1999). Whether the accumulation of one
or more sterol precursors in Epi-Insig-DKO mice is associated
with an inhibition of Shh signaling remains to be determined.
The response of Epi-Insig-DKO mice to topical simvastatin
treatment was dramatic. Unfortunately, we were unable to
find conditions in which the response was limited exclusively
to the region of application, even when we reduced the
volume of simvastatin and the surface area to which it was
applied. Inasmuch as the drug was applied to skin of suckling
pups, the mothers licked the fur of the treated pups, possibly
distributing the drug to other regions of the skin. It is likely
that the drug was absorbed from the skin, released into the
circulation, and taken up by the epidermis where it reduced
the synthesis of sterol precursors in the epidermis.
Although further studies of this model are clearly
indicated, the current data are sufficient to provide insight
into the cutaneous abnormalities that accompany genetic
diseases in which sterol precursors accumulate, because of
the blocks in the cholesterol biosynthetic pathway. Some of
these studies are currently underway in our laboratory.
MATERIALS AND METHODS
Generation of mice lacking Insigs in the epidermis
Mice carrying floxed Insig-1 and null Insig-2 alleles (Insig-1f/f;Insig-
2/) were generated as described (Engelking et al., 2005).
These mice were bred to K14-Cre transgenic mice (stock no.
004782; The Jackson Laboratory, Bar Harbor, ME) to generate
Insig-1f/f;Insig-2/;K14-Cre mice. For simplicity, we designated
these DKO mice lacking Insig-1 and Insig-2 in the epidermis as Epi-
Insig-DKO mice. For all experiments described in this paper, we
bred Insig-1f/wt;Insig-2/;K14-Cre male and Insig-1f/f;Insig-2/
female mice to obtain control (Insig-1f/f;Insig-2/) and Epi-Insig-
DKO littermates. Pregnant females were allowed to pup, and the
date of birth was denoted as PND 1. Mice were genotyped by PCR
using tail genomic DNA with primers described previously (Dassule
et al., 2000; Engelking et al., 2005). The genetic background of the
studied mice was C57BL6/129SvEv/CBA.
All mice were housed in colony cages with a 12h light/12 h dark
cycle and fed ad libitum Teklad Mouse/Rat Diet 7002 (Harlan
Teklad, Indianapolis, IN). All animal experiments were performed
with the approval of the Institutional Animal Care and Research
Advisory Committee at The University of Texas Southwestern
Medical Center at Dallas.
Histology and oil red O staining
For histological analysis, skin from the upper back was collected
from mice at PNDs 4, 7, 14, 21, and 28. The skin was fixed in 10%
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neutral-buffered formalin (catalog no. HT50-1-320; Sigma-Aldrich,
St Louis, MO) for 24–72 hours. For hematoxylin and eosin (H&E)
staining, skin was embedded in paraffin, sectioned parallel or
perpendicular to the hair shaft at 5mm, and stained with H&E. For oil
red O staining, skin was incubated in a 30% aqueous sucrose
solution overnight at 4 1C and embedded in Neg-50 mounting
medium (catalog no. 6506; Thermo Fisher Scientific, Waltham, MA)
and cryosectioned at 10 mm, parallel to the hair shaft. The frozen
sections were stained with a 0.18% oil red O solution (catalog no.
O0625; Sigma-Aldrich) in 60% (v/v) isopropanol for 10minutes and
counterstained with hematoxylin for 1 second.
Determination of tissue sterol composition
Skin from the upper back was harvested from mice at PND 14,
weighed, and placed individually in Folch’s buffer (5ml) containing
5a-cholestane (4mg) and epicoprostanol (4mg) as internal standards.
The skins were then homogenized and centrifuged at 260 g for
5minutes at room temperature to remove debris. The supernatants
were transferred to new glass tubes and then saponified by heating
(100 1C) in ethanolic KOH (100mM) for 2 hours. Lipids were
extracted with petroleum ether (final volume of 6ml), 1/10th of
which (0.6ml) was dried under nitrogen and derivatized with
hexamethyldisilazane-trimethylchlorosilane. GC-MS analysis was
performed using an Agilent 6890N gas chromatograph coupled to
an Agilent 5973 mass selective detector (Agilent Technologies, Santa
Clara, CA). The trimethylsilyl-derivatized sterols were separated on a
DB-35 (35%-phenyl)-methylpolysiloxane capillary column
(30m 0.25mm internal diameter  0.25 mm film) (catalog no.
122-1932; Agilent Technologies) with carrier gas helium at the rate
of 1mlmin1. The temperature program was 150 1C for 2minutes,
followed by increases of 20 1C per min up to 280 1C, which was then
held for 22minutes. For cholesterol, the injector was operated in a
1:10 split mode. For all other sterols, the injector was operated in
splitless mode at 280 1C. The mass spectrometer was operated in the
selective ion-monitoring mode. The mass to charge ratios for the
extracted ions were 343.3 (desmosterol), 350.4 (7-dehydrocholes-
terol), 393.4 (lanosterol), 395.0 (24-dihydrolanosterol), 456.4
(zymosterol), 458.4 (lathosterol), and 458.4 (cholesterol). The
retention time for lathosterol and cholesterol differed by 2minutes.
Immunoblot analysis and immunohistochemistry of HMG-CoA
reductase
A polyclonal antibody against the C-terminal region (amino acids
426 to 887) of mouse HMG-CoA reductase (GenBank accession no.
BC085083) was prepared by immunizing rabbits with purified
bacterially expressed (His)6-tagged protein. Immunoblot analysis of
mouse reductase was carried out as described (Engelking et al.,
2005) except that whole-cell lysates were used. Aliquots of the
lysates (30 mg) were subjected to 8% SDS–PAGE and immunoblot
analysis with 0.3 mgml1 anti-reductase (purified IgG fraction). For
loading control, identical filters were incubated with 0.25 mgml1
monoclonal mouse anti-human transferrin receptor (catalog no.
13-6800; Invitrogen Corp, Camarillo, CA).
For immunohistochemistry, skin sections (prepared as described
for H&E staining) were heated at 58 1C for 15minutes, deparaffi-
nized, and quenched in 0.3% hydrogen peroxide for 30minutes at
room temperature. After incubating overnight at 4 1C with 3 mgml1
anti-reductase antibody, sections were stained with ImmPRESS
Reagent and Peroxidase Substrate kits (catalog nos. MP-7401 and
SK-4100) from Vector Laboratories (Burlingame, CA).
Simvastatin treatment of neonatal mice
A simvastatin stock solution of 6.4mgml1 in propylene glycol/
ethanol (PG/E) was prepared in the following manner. Simvastatin
(800mg) (Merck, Whitehouse Station, NJ) was first dissolved in
ethanol (16ml) at 70 1C and converted to its active hydroxyl acid
form by the addition of 0.6N NaOH (4ml). The resulting solution
was titrated to pH 7.4, and propylene glycol (catalog no. P-1009;
Sigma-Aldrich) was added to give a final PG/E ratio of 7:3 (v/v).
Topical treatments of mice with simvastatin were carried out as
described (Feingold et al., 1990). Briefly, the back skin of each
mouse (0.5–1 cm2) was rubbed for 30 seconds with an acetone-
soaked cotton swab to make the skin permeable. Immediately
thereafter, 156ml of PG/E with or without 1mg simvastatin was
applied to the acetone-treated interscapular area. These treatments
were carried out daily from PND 2 to PND 13, and the mice were
genotyped and photographed at PND 14.
Quantification of sebaceous gland area
Skin from the upper back of PND 14 mice was fixed, cryosectioned,
and stained with oil red O as described above. Photographs of all of
the sebaceous glands in a section were taken, and their area was
quantified using ImageJ (http://rsbweb.nih.gov/ij/index.html). To
gain an accurate quantification, we measured the areas of all
sebaceous glands (more than 150) from 18 individual skin sections
(three mice per group, 6 sections per mouse).
Epidermal barrier assay
The epidermal barrier assay was carried out as described (Hardman
et al., 1998). Briefly, embryos were submerged overnight at 30 1C in
a solution of 2mM MgCl2, 5mM K3Fe(CN)6, 5mM K4Fe(CN)6, 0.01%
(v/v) Triton X, and 1mgml1 X-gal in phosphate-buffered saline. The
solution was adjusted to pH 4.5 using HCl. In the absence of an
intact epidermal barrier, this acidic solution penetrates the epider-
mal barrier and activates endogenous b-galactosidase to produce a
blue precipitate.
Quantitative real-time PCR
Total RNA was prepared from mouse tissues using RNA STAT-60
(Tel-Test, Friendswood, TX). Equal amounts of RNA were
pooled from the tissues of five mice and subjected to quantitative
real-time PCR as described (Liang et al., 2002). A threshold line of
0.15 was set at the exponential phase of the PCR amplification to
determine the number of PCR cycles required (cycle threshold, Ct)
for the sample to reach the threshold level. The relative amount
of all mRNAs was calculated using the comparative Ct method
with cyclophilin as the invariant control. Primers used for
real-time PCR have been described previously (Liang et al., 2002;
Yabe et al., 2003).
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